Wall Street shook off last week’s jitters on Monday, January 26, 2026, climbing in unison with gold, silver and Bitcoin as investors decided that President Trump’s latest tariff broadside was reason enough to hedge—but not to abandon—risk.
Indexes: Risk-On With a Helmet…
Indexes and overall tone
Wall Street limped into the weekend looking more like a tired marathoner than a sprinter, as major U.S. equity indexes closed a volatile, tariff‑tossed week with modest moves that felt heavier than the point changes implied. The S&P…
Wall Street ended Thursday with a relieved shrug and a raised eyebrow, as President Trump’s tariff U‑turn kept risk appetites intact and sent major indexes modestly higher while safe‑haven trades stayed stubbornly in vogue. On balance, Thursday’s tape also suggested a market…
U.S. stocks staged a confident rebound on Wednesday, January 21, 2026, as investors cheered President Donald Trump’s decision to shelve threatened tariffs tied to his Greenland ambitions, turning a geopolitical soap opera into a tradable relief rally that lifted risk assets across…
Silver has been rising because it is caught in a rare sweet spot: a “green-tech” industrial metal in structural shortage that investors suddenly remembered is also money. Add in geopolitical jitters, fading real yields, and a mining sector that has underinvested for…
Biopharma spent 2025 behaving like a sector that has finally read the fine print on the cost of capital—and decided to let someone else pick up the bar tab. Licensing and M&A stepped into the role IPOs used to play, and did…
Wall Street stumbled on Tuesday as investors tried to handicap tariffs, the Fed and Washington all at once, leaving the major indexes split between old‑economy resilience and growth‑stock vertigo.
Indexes: Value Holds Its Nerve
The S&P 500 slid roughly 2.06% on the day, marking…
GSK’s move to acquire RAPT Therapeutics for $2.2 billion reads like the opening chapter of 2026’s biotech M&A season: rich valuation, strategic fit, and just enough risk to keep the buy-side awake. It is also an early signal that Big Pharma’s deal…
America is racing to build the AI future, but Ford’s Jim Farley is warning that the country may run out of people to pour the concrete, pull the cable, and keep the servers humming long before it runs out of capital. At…
U.S. stocks drifted lower in this week, as investors digested early fourth‑quarter earnings, stubbornly mixed inflation data, and a Treasury market that seems determined to remind everyone that “higher for longer” is still a thing, even if no one wants to RSVP.…
